Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Records under this name other than patents Johnson & Johnson Pharmaceutical Research & Development, L.L.C. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,737,162 | Viral Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,852,556 | Animal Model for Evaluating Vasomotor Response in Vivo Formerly held Lapsed on the fee record Ended Oct 7, 2026 · Medium confidence | Lapsed on the fee record | Ended Oct 7, 2026 | Medium confidence |
| US 7,550,474 | Substituted phenyl acetamides and their use as protease inhibitors Term ended Term ended Jun 24, 2026 · From the USPTO record | Term ended | Term ended Jun 24, 2026 | From the USPTO record |
| US 7,317,025 | Non-peptidic NPY Y2 receptor inhibitors Term ended Term ended Nov 26, 2025 · From the USPTO record | Term ended | Term ended Nov 26, 2025 | From the USPTO record |
| US 8,431,704 | Quinoline or Isoquinoline Substituted P2X7 Antagonists Formerly held Lapsed on the fee record Ended Apr 30, 2025 · High confidence | Lapsed on the fee record | Ended Apr 30, 2025 | High confidence |
| US 7,115,598 | Substituted 1,4-diazepines and uses thereof Formerly held Term ended Term ended Oct 1, 2024 · From the USPTO record | Term ended | Term ended Oct 1, 2024 | From the USPTO record |
| US 7,919,476 | Modulation of Glucagon Receptor Expression Formerly held Term ended Ended no later than Apr 27, 2024 · Medium confidence | Term ended | Ended no later than Apr 27, 2024 | Medium confidence |
| US 8,067,367 | Methods of increasing platelet and hematopoietic stem cell production Formerly held Lapsed on the fee record Ended Nov 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 29, 2023 | From the USPTO record |
| US 6,815,445 | Substituted Diphenyloxazoles, the Synthesis Thereof, and the Use Thereof as Fluorescence Probes Formerly held Term ended Term ended Oct 9, 2022 · High confidence | Term ended | Term ended Oct 9, 2022 | High confidence |
| US 7,078,406 | Substituted Diphenyloxazoles, the Synthesis Thereof, and the Use Thereof as Fluorescence Probes Formerly held Term ended Term ended Oct 9, 2022 · High confidence | Term ended | Term ended Oct 9, 2022 | High confidence |